Cite
HARVARD Citation
Liu, F. et al. (2020). Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression. International journal of infectious diseases. pp. 183-191. [Online].